[1]
Rayamajhi, A., Acharya, B. and Khanal, B. 2021. TP53 Mutation as Molecular Marker in the Assessment of Surgical Margin Status in Head and Neck Squamous Cell Carcinoma. Nepalese Journal of Cancer. 5, 1 (Sep. 2021), 27–32. DOI:https://doi.org/10.3126/njc.v5i1.41317.